RxDoctor Payments Data

Rachel Dahlborg, MD

Pediatrics · Osprey, FLNPI 1043506876

Payments from drug & device makers

$997in general payments, 2019–2025

Across 56 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$230
  • Pfizer$221
  • Exact Sciences$107
  • AbbVie$96
  • GSK$65
  • Amgen$56
  • plus $221 from 9 others

What the payments were for

  • Food & beverage$997100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$997 in reported general payments places this provider in the 80th percentile of 3,964 pediatrics providers in Florida.

See all pediatrics providers in Florida

Medicare billing

Part B allowed, 2024
$252,673
Medicare patients
764
Services billed
2,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban114$114,294
OzempicSemaglutide89$97,975
JardianceEmpagliflozin58$91,220
MounjaroTirzepatide48$52,120
MyrbetriqMirabegron47$47,235
TrulicityDulaglutide19$34,160
XareltoRivaroxaban25$31,940
JanuviaSitagliptin Phosphate16$26,391
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$25,713
FarxigaDapagliflozin Propanediol26$24,787
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$11,458
SynthroidLevothyroxine Sodium124$8,537
Spiriva RespimatTiotropium Bromide14$8,171
Advair HfaFluticasone Propion/Salmeterol15$6,325
PremarinEstrogens, Conjugated11$6,007

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin, Paxlovid$221$123,052161 claims
Novo NordiskOzempic$230$97,97589 claims
Lilly USA, LLCMounjaro, Trulicity$29$86,28067 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$65$41,61064 claims
AbbVieSynthroid, Alphagan P$96$11,477139 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,964 pediatrics providers in Florida.

Other pediatrics in Osprey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →